SeqProS possible 383-400 This region binds to GSK3 beta. The binding site of this fragment in GSK3 beta is also the binding site for a fragment of FRAT. The axin fragment and the FRAT fragment share no sequence similarity. The binding sites to GSK3 beta are close, but the modes of binding are different.
Hetero tetramer : IID00052Complex
SeqProS possible 383-401 This region binds to GSK3 beta. The binding site of this fragment in GSK3 beta is also the binding site for a fragment of FRAT. The axin fragment and the FRAT fragment share no sequence similarity. The binding sites to GSK3 beta are close, but the modes of binding are different.
Hetero dimer : IID50236Complex
SeqProS possible 383-401 This region binds to GSK3 beta. The binding site of this fragment in GSK3 beta is also the binding site for a fragment of FRAT. The axin fragment and the FRAT fragment share no sequence similarity. The binding sites to GSK3 beta are close, but the modes of binding are different.
Hetero trimer : IID00052Complex
SeqProS possible 383-401 This region binds to GSK3 beta. The binding site of this fragment in GSK3 beta is also the binding site for a fragment of FRAT. The axin fragment and the FRAT fragment share no sequence similarity. The binding sites to GSK3 beta are close, but the modes of binding are different.
Hetero trimer : IID00052Complex
SeqProS possible 383-401 This region binds to GSK3 beta. The binding site of this fragment in GSK3 beta is also the binding site for a fragment of FRAT. The axin fragment and the FRAT fragment share no sequence similarity. The binding sites to GSK3 beta are close, but the modes of binding are different.
Hetero dimer : IID00052Complex
Component of the beta-catenin destruction complex required for regulating CTNNB1 levels through phosphorylation and ubiquitination, and modulating Wnt-signaling (PubMed:12192039, PubMed:27098453). Controls dorsoventral patterning via two opposing effects; down-regulates CTNNB1 to inhibit the Wnt signaling pathway and ventralize embryos, but also dorsalizes embryos by activating a Wnt-independent JNK signaling pathway (PubMed:12192039). In Wnt signaling, probably facilitates the phosphorylation of CTNNB1 and APC by GSK3B (PubMed:12192039). Likely to function as a tumor suppressor. Enhances TGF-beta signaling by recruiting the RNF111 E3 ubiquitin ligase and promoting the degradation of inhibitory SMAD7 (PubMed:16601693). Also component of the AXIN1-HIPK2-TP53 complex which controls cell growth, apoptosis and development (PubMed:17210684). Facilitates the phosphorylation of TP53 by HIPK2 upon ultraviolet irradiation (PubMed:17210684).